Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma

por Muszbek, Noemi, Remak, Edit, Xin, Qian, McNamara, Linda, Jones, Trefor
Publicado 2023

Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care

por Hawkins, Neil, Muszbek, Noemi, Evans, Rachel, McNamara, Linda, Jones, Trefor
Publicado 2023

Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective

por Borse, Rebekah H., Brown, Chloe, Muszbek, Noemi, Chaudhary, Mohammad Ashraf, Kachroo, Sumesh
Publicado 2017

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Syntheti...

por Muszbek, Noemi, Proudfoot, Clare, Fournier, Marie, Chen, Chieh-I, Kuznik, Andreas, Kiss, Zsofia, Gal, Peter, Michaud, Kaleb
Publicado 2019